Imperatives and Strategies for Ethical Advertising in the Nigerian Pharmaceutical Industry: (A Study of Emzor Pharmaceutical Industries Limited)

Introduction: The Nigerian pharmaceutical industry is growing with the potentials of doing a lot better than it is presently toward achieving medicines security for the country, but it faces critical challenges regarding ethical advertising practices. Ethical advertising is important to ensure pharmaceutical products are promoted transparently protecting consumers’ health and maintaining trust in the sector. This paper examines the imperatives and strategies for ethical advertising within the Nigerian Pharmaceutical Industry using Emzor Pharmaceutical Industries Limited, a major player in the market as case study. By analyzing Emzor’s advertising practices, this study aims to highlight the current ethical standards, identify challenges and propose strategies for improvement.
Methods: This study employed a two-pronged methodological approach; a review of existing literature and content analysis. The review of literature examined relevant academic articles, regulatory guidelines, and industry reports to establish a theoretical framework for ethical advertising in the pharmaceutical sector. This review provided insights into the regulatory space, industry standards, and best practices for ethical advertising. The content analysis was used to assess the actual advertising materials of Emzor Pharmaceutical Industries Limited. This included print materials, digital and broadcast materials. These were analyzed to examine how well they align with ethical standards in terms of accuracy, transparency and comprehensiveness. By comparing how it stands with recommended guidelines and regulatory requirements the study can gauge the company’s compliance to these standards.
Findings/Discussion: The findings reveal that Emzor Pharmaceuticals Industries Limited demonstrates some commitment to ethical advertising as evidenced by adherence to regulatory guidelines and industry standards. The company advertisements generally provide balanced information about medicine efficacy, safety and side effects. It was observed from the content analysis that 63% reported relatively accurate information about advertised medicines while only 16% reported about the inherent risks associated with the medications. A significant proportion of advertisement materials lacked clarity in conveying potential risks associated with the medications which could mislead consumers or healthcare professionals, as there are no medicines without side effects. The literature review and content analysis showed dire needs for ethical advertising in the Nigerian Pharmaceutical sector and the need for enforcement of regulatory guidelines, the need for transparent and accurate communication, and ongoing training for those involved in company’s promotional activities. Some challenges such as competitive pressures and poor regulatory oversight functions were identified as the problem of the Nigerian pharmaceutical industry.
Conclusion: The study concludes that Emzor Pharmaceutical Industries Limited is largely successful in implementing ethical advertising practices but also faces ongoing challenges common to the industry that require attention. For the wider Nigerian Pharmaceutical Industry, the findings underscore the importance of stringent regulatory oversight and clear ethical guidelines. The findings in the industry highlights the need for a comprehensive approach to ethical advertising, incorporating robust internal controls and continuous professional development of those involved in medications promotional functions. Future research should focus on the effectiveness of regulatory interventions and explore how similar strategies can be applied across the entire spectrum of the Nigerian Pharmaceutical sector to improve overall ethical advertising in the industry.

Strategies, Ethical ,Advertising, Nigerian

1. Adeke, A. S., Olorukooba, A. A., & Charles-Amaza, R. (2025).Factors associated with health seeking behaviours and practice of antibiotics self-medication among adults in Abakaliki Metropolis, Ebonyi State, Nigeria. Scientific Reports. https://doi.org/10.1038/s41598-025-91122-9 [Google Scholar] [Crossref]

2. Adibe, M. O., Igboeli, N. U., Ubaka, C. M., Udeogaranya, P. O., Onwudiwe, N. P., & Ita, O. O. (2015).Evaluation of information contained in drug advertisement and promotion materials in Nigeria. Tropical Journal of Pharmaceutical Research, 14(3), 539–544. https://doi.org/10.4314/tjpr.v14i3.25 [Google Scholar] [Crossref]

3. Ahaiwe, E. O. (2019).Advertising media regulation and sale of herbal medicines in Nigeria: Implication for public health and safety. RSU Journal of Strategic and Internet Business, 4(2), 612–631. [Google Scholar] [Crossref]

4. Ajilore, K., Ojo, O. T., & Onyenankeya, K. (2019).Perception of direct-to-consumer pharmaceutical drug advertising in Nigeria. Malaysian Journal of Consumer and Family Economics, 23, 100–122. [Google Scholar] [Crossref]

5. Bélisle-Pipon, J. C. (2022).Pharmaceutical marketing ethics: Ethical standards for more acceptable practices. Journal of Global Marketing, 35(1), 76–98. https://doi.org/10.1080/08911762.2021.1939469 [Google Scholar] [Crossref]

6. Bin Sawad, A. (2021).The general theory of marketing ethics: Conceptual framework for a future study in the pharmaceutical industry. International Journal of Pharmaceutical Research and Allied Sciences, 10(3), 76–82. https://doi.org/10.51847/nwrwrvbwtf [Google Scholar] [Crossref]

7. Boltena, M. T., Wolde, M., Hailu, B., El-Khatib, Z., & Steck, V. (2024).Point prevalence of evidence-based antimicrobial use among hospitalized patients in sub-Saharan Africa: A systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-024-62651-6 [Google Scholar] [Crossref]

8. Erhun, W., & Erhun, M. O. (2003).The qualitative impact of broadcast media advertisement on the perception of medicines in Nigeria. Journal of Consumer Behaviour, 3(1), 8–19. https://doi.org/10.1002/cb.119 [Google Scholar] [Crossref]

9. Ezeome, I. (2021).Conflict of interest in physician–pharmaceutical industry interactions: Possible interventions in Nigeria medical practice. International Journal of Medicine and Health Development, 26(1), 1. https://doi.org/10.4103/ijmh.ijmh_26_20 [Google Scholar] [Crossref]

10. Fadare, J. O., Oshikoya, K. A., Ogunleye, O. O., Desalu, O. O., Ferrario, A., Enwere, O. O., & Godman, B. (2018).Drug promotional activities in Nigeria: Impact on prescribing patterns and practices of medical practitioners and the implications. Hospital Practice, 46(2), 77–87. [Google Scholar] [Crossref]

11. https://doi.org/10.1080/21548331.2018.1437319 [Google Scholar] [Crossref]

12. Federal Republic of Nigeria. (1992).National Agency for Food and Drug Administration and Control Act, Cap. N1. [Google Scholar] [Crossref]

13. Federal Republic of Nigeria. (2004).Counterfeit and Fake Drugs and Unwholesome Processed Foods (Miscellaneous Provisions) Act, Cap. C34 LFN. [Google Scholar] [Crossref]

14. Federal Republic of Nigeria. (2004).Pharmacists Council of Nigeria Act, Cap P17 LFN. [Google Scholar] [Crossref]

15. Federal Republic of Nigeria. (2022).Advertising Regulatory Council of Nigeria Act, 2022. Official Gazette. https://arcon.gov.ng [Google Scholar] [Crossref]

16. Federal Republic of Nigeria. (2022).Pharmacy Council of Nigeria (Establishment) Act, No. 31. [Google Scholar] [Crossref]

17. Fulone, I., Cadogan, C., Barberato-Filho, S., Bergamaschi, C. C., Mazzei, L. G., Lopes, L. P., & Silva, M. T. (2023).Pharmaceutical policies: Effects of policies regulating drug marketing. Cochrane Database of Systematic Reviews, (6). https://doi.org/10.1002/14651858.CD013780.pub2 [Google Scholar] [Crossref]

18. Hubbard, J. E. (2007).The dangers of detailing: How pharmaceutical marketing threatens health care. University of Tennessee Theses and Dissertations. https://trace.tennessee.edu/utk_gradthes/144 [Google Scholar] [Crossref]

19. Jolibert, A., Mühlbacher, H., Florès, L., & Dubois, P.-L. (2012).Strategic branding. In Marketing Management. https://doi.org/10.1007/978-0-230-36367-0_7 [Google Scholar] [Crossref]

20. Malik, F., Junaid, M., & Asif, M. (2024).Exploring ethical issues in pharmaceutical marketing’s strategies: A critical marketing perspective. SSRN Electronic Journal. [Google Scholar] [Crossref]

21. https://doi.org/10.2139/ssrn.4831879 [Google Scholar] [Crossref]

22. Man, E. J. M. S., Akpan, A. O., Sampson, A., & Udoka, M. O. (2022).Drug advertising and purchase behaviour of residents of Uyo Metropolis: A study of the retail pharmaceutical industry. European Journal of Marketing and Management Sciences, 4(1), 1–18. [Google Scholar] [Crossref]

23. https://aspjournals.org/Journals/index.php/ejmms/index [Google Scholar] [Crossref]

24. Momodu, R. O., Odigie, R., & Udezi, W. A. (2018).Drug labelling information and advertisements: Extent of use as sources of drug information by members of the public in Lagos, Nigeria. Nigerian Journal of Pharmaceutical and Applied Science Research, 7(2), 80–88. [Google Scholar] [Crossref]

25. Mühlhoff, R., & Willem, T. (2023).Social media advertising for clinical studies: Ethical and data protection implications of online targeting. Big Data & Society, 10(1). [Google Scholar] [Crossref]

26. https://doi.org/10.1177/20539517231156127 [Google Scholar] [Crossref]

27. Onuorah, J. (1999).Imperatives of advertising regulation. Nigerian Journal of Marketing, 3(2), 144–150. [Google Scholar] [Crossref]

28. Oshikoya, K. A., Senbanjo, I. Q., & Soipe, A. (2009).Adequacy of pharmacological information in pharmaceutical drug advertisements in African medical journals. Pharmacy Practice, 7(2), 100–107. https://doi.org/10.4321/S1886-3655200900020000 [Google Scholar] [Crossref]

29. Radenković, M., Lazarević, I., & Stojanović, M. (2019).Ethical challenges related to marketing drugs. In The Bioethics of the Crazy Ape (pp. 207–222). Trivent Publishing. https://trivent-publishing.eu/books/thebioethicsofthecrazyape/19.MiroslavRadenkovic.pdf [Google Scholar] [Crossref]

30. Siddiq, A., Khan, A., Ali, N., & Ali, Z. (2021).Unethical marketing practices by pharmaceutical industry in Pakistan. Webology, 18(6), 7089. http://www.webology.org [Google Scholar] [Crossref]

31. Smith, N. C. (2012).Laying foundations for an emerging field: A commentary on Shelby Hunt’s research on marketing ethics. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.1668527 [Google Scholar] [Crossref]

32. Ud, Z., Babar, D., Izham, M., Ibrahim, M., Singh, H., Bukahri, N. I., & Creese, A. (2007). [Google Scholar] [Crossref]

33. Evaluating drug prices, availability, affordability, and price components: Implications for access to drugs in Malaysia. PLoS Medicine, 4(3), e82. https://doi.org/10.1371/journal.pmed.0040082 [Google Scholar] [Crossref]

34. Uduji, J. I. (2012).Ethical and legal responsibilities of marketing managers in the pharmaceutical industry in Nigeria. International Journal of Business Ethics, 23(1), 1–9. [Google Scholar] [Crossref]

35. Ventola, C. L. (2011). Direct-to-consumer pharmaceutical advertising: Therapeutic or toxic? P&T, 36(10), 669–684. [Google Scholar] [Crossref]

36. Vermillion, L., Winsor, R. D., & Lassar, W. M. (2003).The Hunt–Vitell general theory of marketing ethics: Can it enhance our understanding of principal-agent relationships in channels of distribution? Journal of Business Ethics, 103(3), 239–248. https://doi.org/10.1023/A [Google Scholar] [Crossref]

37. World Health Organization. (1988).Ethical criteria for medicinal drug promotion. https://apps.who.int/iris/handle/10665/38125 [Google Scholar] [Crossref]

38. Yenet, A., Nibret, G., & Tegegne, B. A. (2023).Challenges to the availability and affordability of essential medicines in African countries: A scoping review. ClinicoEconomics and Outcomes Research, 15, 443–458. https://doi.org/10.2147/CEOR.S413722 [Google Scholar] [Crossref]

39. Yousefi, N., Sharif, Z., Chahian, F., Mombeini, T., & Peiravian, F. (2022).An investigation into the pharmaceutical advertising in Iranian medical journals. Journal of Pharmaceutical Policy and Practice, 15(1), 1–10. https://doi.org/10.1186/s40545-022-00415-1 [Google Scholar] [Crossref]

40. Zaikauskaitė, L., Butler, G., Helmi, N. F. S., Robinson, C. L., Treglown, L., Tsivrikos, D., & Devlin, J. T. (2022).Hunt–Vitell’s general theory of marketing ethics predicts attitude–behaviour gap in pro-environmental domain. Frontiers in Psychology, 13, 732661. https://doi.org/10.3389/fpsyg.2022.732661 [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar